Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00838071|
Recruitment Status : Completed
First Posted : February 6, 2009
Last Update Posted : February 6, 2009
Instituto Grifols, S.A.
Information provided by:
Grifols Biologicals Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||July 2004|
|Actual Study Completion Date :||August 2004|